Get Premium to unlock powerful stock data

Aquilo Capital Management, LLC Buys 4D Molecular Therapeutics Inc, Amryt Pharma PLC, uniQure NV, Sells Harpoon Therapeutics Inc

Author's Avatar
insider
Sep 02, 2021
Article's Main Image
Investment company Aquilo Capital Management, LLC (Current Portfolio) buys 4D Molecular Therapeutics Inc, Amryt Pharma PLC, uniQure NV, Galapagos NV, sells Harpoon Therapeutics Inc during the 3-months ended 2021Q2, according to the most recent filings of the investment company, Aquilo Capital Management, LLC. As of 2021Q2, Aquilo Capital Management, LLC owns 15 stocks with a total value of $385 million. These are the details of the buys and sells.

For the details of Aquilo Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/aquilo+capital+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Aquilo Capital Management, LLC
  1. Dicerna Pharmaceuticals Inc (DRNA) - 1,813,392 shares, 17.58% of the total portfolio. Shares added by 6.33%
  2. Spero Therapeutics Inc (SPRO) - 3,829,209 shares, 13.89% of the total portfolio.
  3. Blueprint Medicines Corp (BPMC) - 448,512 shares, 10.25% of the total portfolio. Shares added by 6.03%
  4. Arrowhead Pharmaceuticals Inc (ARWR) - 432,926 shares, 9.32% of the total portfolio. Shares added by 6.13%
  5. uniQure NV (QURE) - 1,157,513 shares, 9.26% of the total portfolio. Shares added by 21.15%
New Purchase: Amryt Pharma PLC (AMYT)

Aquilo Capital Management, LLC initiated holding in Amryt Pharma PLC. The purchase prices were between $10.9 and $14.29, with an estimated average price of $12.44. The stock is now traded at around $10.910000. The impact to a portfolio due to this purchase was 3.59%. The holding were 1,140,000 shares as of 2021-06-30.

Added: 4D Molecular Therapeutics Inc (FDMT)

Aquilo Capital Management, LLC added to a holding in 4D Molecular Therapeutics Inc by 214.20%. The purchase prices were between $22.2 and $43.38, with an estimated average price of $30.89. The stock is now traded at around $32.550000. The impact to a portfolio due to this purchase was 4.04%. The holding were 945,382 shares as of 2021-06-30.

Added: uniQure NV (QURE)

Aquilo Capital Management, LLC added to a holding in uniQure NV by 21.15%. The purchase prices were between $29.97 and $37.17, with an estimated average price of $33.54. The stock is now traded at around $30.570000. The impact to a portfolio due to this purchase was 1.62%. The holding were 1,157,513 shares as of 2021-06-30.

Added: Galapagos NV (GLPG)

Aquilo Capital Management, LLC added to a holding in Galapagos NV by 21.95%. The purchase prices were between $68.86 and $83.34, with an estimated average price of $76.32. The stock is now traded at around $60.475000. The impact to a portfolio due to this purchase was 0.46%. The holding were 142,340 shares as of 2021-06-30.

Reduced: Harpoon Therapeutics Inc (HARP)

Aquilo Capital Management, LLC reduced to a holding in Harpoon Therapeutics Inc by 54.15%. The sale prices were between $13.81 and $23.25, with an estimated average price of $19.15. The stock is now traded at around $9.350000. The impact to a portfolio due to this sale was -3.25%. Aquilo Capital Management, LLC still held 712,674 shares as of 2021-06-30.



Here is the complete portfolio of Aquilo Capital Management, LLC. Also check out:

1. Aquilo Capital Management, LLC's Undervalued Stocks
2. Aquilo Capital Management, LLC's Top Growth Companies, and
3. Aquilo Capital Management, LLC's High Yield stocks
4. Stocks that Aquilo Capital Management, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus